In focus
Latest feed
Biotech M&A Fever: Eli Lilly's Bold Bets Spark Retail Trader Excitement for Sellas and ImmunityBio
EyePoint's Wild Ride: A Failed Trial, Massive Losses, and a Glimmer of Hope
Roquette's Remarkable Resilience: Navigating Choppy Waters with Strategic Growth
Pfizer's Recent Rally: A Fleeting Illusion or Sustainable Recovery?
